View source for ESC 2015 Schedule

÷
Here is the page we will use to coordinate the TV events at ESC 2015. Open time slots are indicated below in red.

Filming Location: Crowne Plaza London - Dockland, Western Gateway, Royal Victoria Dock, London, E16 1AL, United Kingdom
----
__NOTOC__

== Click on Date for Detailed Schedule ==

[[{{PAGENAME}}#Sunday, August 30, 2015| Sunday, August 30, 2015]]

[[{{PAGENAME}}#Monday, August 31, 2015| Monday, August 31, 2015]]

[[{{PAGENAME}}#Tuesday, September 1, 2015| Tuesday, September 1, 2015]]

[[{{PAGENAME}}#Wednesday, September 2, 2015| Wednesday, September 2, 2015]]

----
== Sunday, August 30, 2015 ==

=== 4:30 PM ===
* '''Interviewee:''' Dr. Robert Byrne
* '''Topic:''' ESC 2015 Wrap-Up from the Perspective of the UK/Ireland

== Monday, August 31, 2015 ==

=== 8:00 AM ===
<font color=red>OPEN TIME SLOT</font>

=== 8:30 AM ===
* '''Interviewee:''' Dr. Vivek Reddy
* '''Topic:''' Safety and efficacy of a Leadless pacemaker: results from the LEADLESS II clinical trial
* '''Embargo Lift:''' Sunday, August 30th at 5:38 PM

=== 9:00 AM ===
<font color=red>OPEN TIME SLOT</font>

=== 9:30 AM ===
* '''Interviewee: ''' Dr. Kazuaki Kaitani (and Dr. Atsushi Kobori)
* '''Topic: ''' Efficacy of Antiarrhythmic drugs Short-Term use after catheter ablation for Atrial Fibrillation (EAST-AF) Trial '''AND '''Efficacy of adenosine triphosphate guided ablation for atrial fibrillation: UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate (UNDER-ATP) Trial
* '''Embargo Lift:''' Sunday, August 30th at 4:30 PM''' and''' Sunday, August 30th at 4:30 PM

=== 10:00 AM ===
* '''Interviewee:''' Pr. Michel Ovize
* '''Topic:''' Does cyclosporine improve clinical outcomes in STEMI patients? The CIRCUS trial
* '''Embargo Lift: '''Sunday, August 30th, at 12:27 PM

=== 10:30 AM ===
<font color=red>OPEN TIME SLOT</font>

=== 11:30 AM ===
* '''Interviewee:''' Dr. Morris Brown
* '''Topic:''' Principal results from Prevention And Treatment of Hypertension With Algorithm based therapY (PATHWAY): comparison of single and combination diuretics in essential hypertension - PATHWAY-3
* '''Embargo Lift:''' Monday August 31st at 5:16 PM

=== 12:00 PM ===
* '''Interviewee:''' Dr. Luigi Di Biase
* '''Topic:''' Effect of empirical left atrial appendage isolation on long-term procedure outcome in patients with long-standing persistent atrial fibrillation undergoing catheter ablation: results from the BELIEF      
* '''Embargo Lift:''' Sunday, August 30th at 4:53 PM

=== 12:30 PM ===
<font color=red>OPEN TIME SLOT</font>

=== 1:00 PM ===
<font color=red>OPEN TIME SLOT</font>

=== 1:30 PM ===
* '''Interviewee:''' Dr. Eldrin Lewis
* '''Topic:''' The evaluation of Lixisenatide in acute coronary syndromes (ELIXA).
* '''Embargo Lift:''' Monday, August 31st at 11:36 AM

=== 2:00 PM ===
<font color=red>OPEN TIME SLOT</font>

=== 2:30 PM ===
* '''Interviewee:''' Dr. Dirk Westermann
* '''Topic: '''Accurate and rapid diagnosis of myocardial infarction using a high sensitivity Troponin I 1-hour algorithm
* '''Embargo Lift:''' Sunday, August 30th at 11:00 AM

=== 3:00 PM ===
* '''Interviewee:''' Dr. Basil Lewis
* '''Topic: '''ESC 2015 Wrap-up in Hebrew

=== 3:30 PM ===
* '''Interviewee:''' Dr. Renato Lopes
* '''Topic:''' ESC 2015 Wrap-up in Portuguese

=== 4:00 PM ===
* '''Interviewee:''' Pr. Freek Verheugt
* '''Topic: '''ESC 2015 Wrap-up from the Perspective of the Netherlands 

=== 4:30 PM ===
<font color=red>OPEN TIME SLOT</font>

== Tuesday, September 1, 2015 ==

=== 8:00 AM ===
<font color=red>OPEN TIME SLOT</font>

=== 8:30 AM ===
<font color=red>OPEN TIME SLOT</font>

=== 9:00 AM ===
<font color=red>OPEN TIME SLOT</font>

=== 9:30 AM ===
* '''Interviewee: ''' Dr. Takeshi Kimura
* '''Topic: '''ABSORB Japan: 12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs. metallic drug-eluting stent
* '''Embrago Lift: '''Tuesday, September 1st at 5:06 PM

=== 10:00 AM ===
* '''Interviewee:''' Dr. Gérard Helft
* '''Topic: '''The OPTIDUAL trial: 12 vs 48 months of clopidogrel after drug-eluting stent placement
* '''Embargo Lift: '''Monday, August 31st at 12:12 PM

=== 10:30 AM ===
* '''Interviewee:''' Dr. Pamela Douglas
* '''Topic:''' Outcomes of an FFRCT diagnostic strategy versus usual care in suspected coronary artery disease: results from the PLATFORM (Prospective LongitudinAl Trial of FFRCT: Outcome and Resource IMpacts) study
* '''Embargo Lift:''' Tuesday, September 1st at 4:30 PM

=== 11:00 AM ===
* '''Interviewee:''' Dr. Hisao Ogawa
* '''Topic: '''A trial of Telmisartan prevention of cardiovascular diseases (ATTEMPT-CVD) : the large biomarkers study with 1228 patients '''AND '''ESC 2015 Wrap-up in''' '''Japanese
* '''Embargo Lift:''' Monday August 31st at 4:30 PM 

=== 11:30 AM ===
* '''Interviewee:''' Dr. Marco Valgimigli
* '''Topic: '''Minimizing Adverse haemorrhagic events by TRansradial access site and systemic Implementation of angioX (MATRIX Antithrombin)
* '''Embargo Lift:''' Tuesday, September 1st at 5:24 PM

=== 12:00 PM ===
* '''Interviewee:''' Pr. Thomas MacDonald
* '''Topic: '''The Standard care versus Celecoxib Outcome Trial (SCOT); a randomised, trial comparing the cardiovascular safety of celecoxib versus traditional non-steroidal anti-inflammatory drugs.
* '''Embargo Lift:''' Monday, August 31st at 11:54 AM

=== 12:30 PM ===
<font color=red>OPEN TIME SLOT</font>

=== 1:00 PM ===
* '''Interviewee:''' Dr. Gregg Stone
* '''Topic:''' Peri-infarct zone pacing to prevent adverse left ventricular remodeling in patients with very large myocardial infarction
* '''Embargo Lift: '''Sunday, August 30th at 11:54 AM

=== 1:30 PM ===
* '''Interviewee:''' Dr. Patrick Serruys
* '''Topic: '''Everolimus-eluting bioresorbable vascular scaffolds versus durable polymer everolimus-eluting metallic stents in patients with acute myocardial infarction. Results of the ABSORB STEMI TROFI II trial.
* '''Embargo Lift: '''Tuesday, September 1st at 4:48 PM

=== 2:00 PM ===
* '''Interviewee: ''' Dr. Frank Rademakers
* '''Topic: '''Determining Optimal non-invasive Parameters for the Prediction of Left vEntricular morphologic and functional Remodeling in Chronic Ischemic Patients
* '''Embrago Lift: '''Sunday, August 30th at 11:18 AM

=== 3:00 PM ===
* '''Interviewee: '''Dr. Gerasimos Filippatos
* '''Topic:''' Finerenone versus eplerenone in patients with worsening chronic heart failure with type 2 diabetes mellitus and/or chronic kidney disease: main results of the ARTS-HF trial
* '''Embargo Lift:''' Monday, August 31st at 11:18 AM

=== 3:30 PM ===
* '''Interviewee:''' Dr. Carlos A. Morillo
* '''Topic: '''The BENznidazole Evaluation For Interrupting Trypanosomiasis trial
* '''Embargo Lift:''' Tuesday, September 1st at 12:08 PM

=== 4:00 PM ===
* '''Interviewee: '''Dr. Stefan James (and guest Dr. Jonas Oldgren)
* '''Topic: '''Wrap-up from a Scandinavian Perspective

=== 4:30 PM ===
* '''Interviewee: ''' Dr. Sergio Leonardi (and guest Pr. Gaetano De Ferrari)
* '''Topic: '''ESC 2015 Wrap-Up in Italian

=== 5:00 PM - 6:00 PM ===
* Interviewee: Pr. Gilles Montalescot
* Topic: Early aldosterone blockade in acute myocardial infarction: the randomized ALBATROSS Trial '''AND''' Assessment of an education and guidance program for apixaban adherence in non-valvular atrial fibrillation: the randomized AEGEAN study '''AND''' ESC 2015 Wrap-up in''' '''French
* Embargo Lift: Sunday, August 30th at 11:36 AM (ALBATROSS) '''and '''Sunday, August 30th at 5:16 PM (AEGEAN)

== Wednesday, September 2, 2015 ==

=== 8:00 AM ===
<font color=red>OPEN TIME SLOT</font>

=== 8:30 AM ===
<font color=red>OPEN TIME SLOT</font>

=== 9:00 AM ===

* '''Interviewee: ''' Pr. Harvey White
* '''Topic: ''' ESC 2015 Wrap-Up from Perspective from the Pacific Rim

=== 9:30 AM ===
* '''Interviewee: ''' Pr. Sigmund Silber
* '''Topic: '''        ESC 2015 Wrap-Up in German